Ab&B Bio-Tech CO., LTD. JS — Board/Management Information 2026

Apr 19, 2026

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

中華總會

Ab&B Bio-Tech

Ab&B Bio-Tech CO., LTD. JS

江蘇中華大學工業研究所

(A joint stock company established in the People's Republic of China with limited liability)

(Stock Code: 2627)

ANNOUNCEMENT

(I) PROPOSED ABOLITION OF THE SUPERVISORY COMMITTEE

(II) PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION

AND

(III) CHANGE IN MEMBERS OF STRATEGY COMMITTEE OF THE BOARD

The board (the "Board") of directors (the "Directors") of Ab&B Bio-Tech CO., LTD. JS (the "Company" or "Ab&B Bio-Tech", together with its subsidiary, the "Group") proposes to (i) abolish the supervisory committee (the "Supervisory Committee") of the Company (the "Abolition of the Supervisory Committee"); (ii) make certain amendments (the "Proposed Amendments") to the articles of association of the Company (the "Articles of Association") and (iii) change members of the Strategy Committee of the Board.

PROPOSED ABOLITION OF THE SUPERVISORY COMMITTEE

Pursuant to the Company Law of the People's Republic of China (the "PRC Company Law") and other applicable laws, regulations and normative documents, and having regard to the actual circumstances of the Company, the Board proposes to abolish the Supervisory Committee subject to the consideration and approval by the Shareholders. The functions and powers of the Supervisory Committee as stipulated under the PRC Company Law will be assumed by the Audit Committee of the Company. Accordingly, the existing positions of the supervisors will be terminated, and the rules of procedures for the Supervisory Committee meetings of the Company will be abolished.

PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION

The Board proposed to make certain amendments to the Articles of Association for the purposes of, among others, (i) updating and bringing the Articles of Association in line with the latest regulatory requirements under the PRC Company Law and the other relevant laws and regulations, in particular to reflect the proposed Abolition of the Supervisory Committee; (ii) better aligning the Articles of Association with the actual circumstances and needs of the Company; and (iii) other housekeeping changes (e.g. textual clean-ups, numbering updates and other refinements).

---

2

CHANGE IN MEMBERS OF STRATEGY COMMITTEE OF THE BOARD

The Board announces that, the change in members of the Strategy Committee of the Board has been approved with effect from the date of approval by the Board. The members after adjustment are as follows:

Chairman: Mr. An Youcai

Members: Mr. He Yiming, Mr. Li Xiangming

GENERAL

The proposed Abolition of the Supervisory Committee and proposed amendments to the Articles of Association shall be subject to the consideration and approval at the shareholders’ general meeting to be held by the Company by way of special resolution. A circular of the Company (including the notice of the general meeting) containing details of, among other things, the proposed Abolition of the Supervisory Committee and the proposed amendments to the Articles of Association will be dispatched to the shareholders of the Company in due course.

By Order of the Board

Ab&B Bio-Tech CO., LTD. JS

Mr. AN Youcai

Executive Director, chairman of our Board and general manager

Hong Kong, April 19, 2026

As at the date of this announcement, the Board comprises: (i) Mr. AN Youcai, Ms. LI Runxiang and Mr. HE Yiming as executive Directors; (ii) Mr. CHENG Qianwen, Mr. YU Jianlin and Mr. DU Mu as non-executive Directors; and (iii) Mr. LI Xiangming, Mr. LI Jianjun and Mr. CHEN Chengbei as independent non-executive Directors.